Cart
sales@molnova.com
Home - Products - Cell Cycle/DNA Damage - Integrin - Elarofiban

Elarofiban

CAS No. 198958-88-2

Elarofiban( —— )

Catalog No. M34233 CAS No. 198958-88-2

Elarofiban(RWJ-53308) is a novel and orally active GPIIb/IIIa antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 922 In Stock
10MG 1226 In Stock
25MG 1853 In Stock
50MG 2437 In Stock
100MG 3283 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Elarofiban
  • Note
    Research use only, not for human use.
  • Brief Description
    Elarofiban(RWJ-53308) is a novel and orally active GPIIb/IIIa antagonist.
  • Description
    Elarofiban (RWJ-53308) is a nonpeptide, orally active fibrinogen receptor antagonist. Elarofiban has the potential for platelet mediated thrombotic disorders research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    Integrin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    198958-88-2
  • Formula Weight
    416.51
  • Molecular Formula
    C22H32N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H](NC(=O)[C@H]1CN(C(CCC2CCNCC2)=O)CCC1)(CC(O)=O)C=3C=CC=NC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Judith H. Cohen, et al. A Practical Synthesis of the Platelet Fibrinogen Antagonist, Elarofiban. Organic Process Research & Development 2003, 7, 866-872.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Zaurategrast

    A potent and selective, orally bioavailable α4 integrin (α4β1/VLA-4 and, to a lesser extent, α4β7 integrin) antagonist.

  • BMS-688521

    BMS-688521 BMS-688521 is an orally active and potent inhibitor of LFA-1/ICAM interaction, a small molecule antagonist of leukocyte function-associated antigen-1 (LFA-1), with potential anti-inflammatory activity.

  • Gantofiban

    Gantofiban is a glycoprotein IIb/IIIa (GP IIb/IIIa) antagonist used in the treatment of cardiovascular disease and may be used to study thrombosis.

Sign In Join Free